Suppr超能文献

Vav家族鸟嘌呤核苷酸交换因子在EphA受体介导的血管生成中的重要作用。

Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.

作者信息

Hunter Sonja G, Zhuang Guanglei, Brantley-Sieders Dana, Swat Wojciech, Cowan Christopher W, Chen Jin

机构信息

Vanderbilt University School of Medicine, A-4323 MCN, 1161 21st Avenue South, Nashville, TN 37232-2363, USA.

出版信息

Mol Cell Biol. 2006 Jul;26(13):4830-42. doi: 10.1128/MCB.02215-05.

Abstract

Angiogenesis, the process by which new blood vessels are formed from preexisting vasculature, is critical for vascular remodeling during development and contributes to the pathogenesis of diseases such as cancer. Prior studies from our laboratory demonstrate that the EphA2 receptor tyrosine kinase is a key regulator of angiogenesis in vivo. The EphA receptor-mediated angiogenic response is dependent on activation of Rho family GTPase Rac1 and is regulated by phosphatidylinositol 3-kinase. Here we report the identification of Vav2 and Vav3 as guanine nucleotide exchange factors (GEFs) that link the EphA2 receptor to Rho family GTPase activation and angiogenesis. Ephrin-A1 stimulation recruits the binding of Vav proteins to the activated EphA2 receptor. The induced association of EphA receptor and Vav proteins modulates the activity of Vav GEFs, leading to activation of Rac1 GTPase. Overexpression of either Vav2 or Vav3 in primary microvascular endothelial cells promotes Rac1 activation, cell migration, and assembly in response to ephrin-A1 stimulation. Conversely, loss of Vav2 and Vav3 GEFs inhibits Rac1 activation and ephrin-A1-induced angiogenic responses both in vitro and in vivo. In addition, embryonic fibroblasts derived from Vav2-/- Vav3-/- mice fail to spread on an ephrin-A1-coated surface and exhibit a significant decrease in the formation of ephrin-A1-induced lamellipodia and filopodia. These findings suggest that Vav GEFs serve as a molecular link between EphA2 receptors and the actin cytoskeleton and provide an important mechanism for EphA2-mediated angiogenesis.

摘要

血管生成是指从已有的脉管系统形成新血管的过程,对于发育过程中的血管重塑至关重要,并且在诸如癌症等疾病的发病机制中发挥作用。我们实验室先前的研究表明,EphA2受体酪氨酸激酶是体内血管生成的关键调节因子。EphA受体介导的血管生成反应依赖于Rho家族GTP酶Rac1的激活,并受磷脂酰肌醇3激酶调节。在此,我们报告鉴定出Vav2和Vav3作为鸟嘌呤核苷酸交换因子(GEF),它们将EphA2受体与Rho家族GTP酶激活及血管生成联系起来。Ephrin-A1刺激促使Vav蛋白与活化的EphA2受体结合。EphA受体与Vav蛋白的诱导性结合调节Vav GEF的活性,导致Rac1 GTP酶激活。在原代微血管内皮细胞中过表达Vav2或Vav3可促进Rac1激活、细胞迁移以及对ephrin-A1刺激的组装反应。相反,Vav2和Vav3 GEF的缺失在体外和体内均抑制Rac1激活以及ephrin-A1诱导的血管生成反应。此外,源自Vav2-/- Vav3-/-小鼠的胚胎成纤维细胞无法在ephrin-A1包被的表面铺展,并且在ephrin-A1诱导的片状伪足和丝状伪足形成方面显著减少。这些发现表明,Vav GEF作为EphA2受体与肌动蛋白细胞骨架之间的分子连接,为EphA2介导的血管生成提供了重要机制。

相似文献

3
Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
J Biol Chem. 2008 Jun 6;283(23):16017-26. doi: 10.1074/jbc.M709934200. Epub 2008 Apr 3.
4
Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Biochemistry. 2005 May 3;44(17):6573-85. doi: 10.1021/bi047443q.
6
VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2.
Exp Cell Res. 2007 Sep 10;313(15):3285-97. doi: 10.1016/j.yexcr.2007.05.027. Epub 2007 Jun 29.
7
The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration.
Cardiovasc Res. 2010 Apr 1;86(1):131-40. doi: 10.1093/cvr/cvp387. Epub 2009 Dec 7.

引用本文的文献

1
Increased fatty acid delivery by tumor endothelium promotes metastatic outgrowth.
JCI Insight. 2025 Apr 8;10(9). doi: 10.1172/jci.insight.187531. eCollection 2025 May 8.
3
Regulation of fatty acid delivery to metastases by tumor endothelium.
bioRxiv. 2024 Apr 3:2024.04.02.587724. doi: 10.1101/2024.04.02.587724.
4
Arteriovenous malformation Map2k1 mutation affects vasculogenesis.
Sci Rep. 2023 Jul 8;13(1):11074. doi: 10.1038/s41598-023-35301-6.
6
Vav2 is a novel APP-interacting protein that regulates APP protein level.
Sci Rep. 2022 Jul 26;12(1):12752. doi: 10.1038/s41598-022-16883-z.
7
in gastrointestinal cancer: Expression, regulation and clinical significance.
World J Gastrointest Oncol. 2022 May 15;14(5):973-988. doi: 10.4251/wjgo.v14.i5.973.
8
DOCK4 Regulation of Rho GTPases Mediates Pulmonary Vascular Barrier Function.
Arterioscler Thromb Vasc Biol. 2022 Jul;42(7):886-902. doi: 10.1161/ATVBAHA.122.317565. Epub 2022 Apr 28.
10
Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4.
Cell Chem Biol. 2022 Jun 16;29(6):970-984.e6. doi: 10.1016/j.chembiol.2022.01.007. Epub 2022 Feb 10.

本文引用的文献

1
EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
EMBO J. 2006 Feb 8;25(3):628-41. doi: 10.1038/sj.emboj.7600949. Epub 2006 Jan 19.
2
Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.
FASEB J. 2005 Nov;19(13):1884-6. doi: 10.1096/fj.05-4038fje. Epub 2005 Sep 15.
3
A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.
Oncogene. 2005 Nov 24;24(53):7859-68. doi: 10.1038/sj.onc.1208937.
4
Eph receptor signalling casts a wide net on cell behaviour.
Nat Rev Mol Cell Biol. 2005 Jun;6(6):462-75. doi: 10.1038/nrm1662.
5
Vav family GEFs link activated Ephs to endocytosis and axon guidance.
Neuron. 2005 Apr 21;46(2):205-17. doi: 10.1016/j.neuron.2005.03.019.
7
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
Curr Pharm Des. 2004;10(27):3431-42. doi: 10.2174/1381612043383160.
8
Eph receptor tyrosine kinases in angiogenesis: from development to disease.
Angiogenesis. 2004;7(1):17-28. doi: 10.1023/B:AGEN.0000037340.33788.87.
9
Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins.
Cell Signal. 2004 Jun;16(6):655-66. doi: 10.1016/j.cellsig.2003.10.006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验